AAM_Mutual_benefit_added_value.pdf (382 kB)
Mutual benefit, added value? Doing research in the National Health Service
The National Health Service (NHS) has recently been the focus of government efforts to retain pharmaceutical research in the UK. Efforts to foster new partnerships between health care providers and industry have been framed with suggestions that clinical trials can offer patient benefit within the NHS, cutting across ethical and sociological concerns with the possible tension between doing research and offering care. This paper draws on ethnographic research to explore the sometimes awkward juxtapositions between trial protocols and everyday care, individual health and commercial profit, and thus the distribution of value produced through trials. While researchers appear to find the distinction between research and care useful, at least some of the time, both formal and informal strategies for living with this distinction may have the unintended consequence of making research appear supplementary to rather than simply different from clinical care.
History
Publication status
- Published
File Version
- Accepted version
Journal
Journal of Cultural EconomyISSN
1753-0350Publisher
Taylor & FrancisExternal DOI
Issue
1Volume
4Page range
11-26Pages
16.0Department affiliated with
- Sociology and Criminology Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-06First Open Access (FOA) Date
2016-03-22First Compliant Deposit (FCD) Date
2016-11-16Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC